ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$MEDP:NASDAQ · MEDPACE HLDGS INC

Sector: health

Conviction from: NASDAQ

52-week range: 373.00693.97

Medpace is a clinical contract research organization that provides outsourced drug and device development services, managing clinical trials for biopharmaceutical and medical-device companies.

6 tracked filer(s) hold this · 2 opened, 1 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 61 — mean of 6 scored holder(s) · buyers (new/add) avg 64. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy846$528,0560.0%
Steve Cohen / Point7275New buy15,812$9,869,5340.0%
Bridgewater55Added +269%57,506$35,894,0950.2%
Ancora42Holds (flat)42$26,2160.0%
François Rochon / Giverny69Trimmed -52%244,746$152,765,5585.2%
Terry Smith / Fundsmith66Trimmed -50%25,940$16,191,2290.1%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

6 disclosed trade(s) by 2 filer(s).

Trade dateWhoTypeAmount
2026-05-15David J. Taylor OH02BUY$1,001 - $15,000PTR
2026-05-15David J. Taylor OH02BUY$1,001 - $15,000PTR
2026-02-26David J. Taylor OH02BUY$1,001 - $15,000PTR
2026-01-29David J. Taylor OH02BUY$1,001 - $15,000PTR
2026-01-16David J. Taylor OH02SELL$1,001 - $15,000PTR
2026-01-15Gilbert Cisneros CA31SELL$15,001 - $50,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.